TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
SLDB

Solid Biosciences LLC

Healthcare · Biotechnology

6.90$ -1.9% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Solid Biosciences LLC (SLDB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 421 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SLDB
Line item Q1 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
– 41 – – 35 76 189 171 157 140 120 96 131 103 74 58 41 171 285 266 249 232 208 208 184 260 230 205 185 165 249 231 212 189 344 308 274 233 423 421
– 40 38 – 31 71 184 164 148 129 102 78 113 86 58 44 27 159 274 255 239 223 199 170 148 220 191 167 148 130 214 198 179 157 313 279 245 205 397 395
– 7.7 -38 – 15 52 165 146 129 86 54 52 95 76 53 40 25 155 268 201 110 119 130 54 49 155 165 92 49 74 118 96 64 80 211 139 61 60 298 159
– 38 38 – 30 69 182 163 145 122 95 67 106 84 54 40 25 155 268 249 230 208 180 163 142 214 186 160 143 124 206 190 171 149 307 268 236 188 381 378
– – – – – – – – – – – – – – – – – – 0.3 0.6 1.3 0.1 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – –
– – – – – – 0.0 0.0 0.0 – – – – – – – – – 2.1 2.0 4.7 6.0 0.0 – – – – – – – – – – – – – – – – –
– 0.5 – – 2.3 2.4 4.4 6.6 7.9 10 18 17 17 17 16 14 8.9 12 7.5 8.7 6.9 6.5 6.8 36 35 9.7 8.6 35 – – – – – – – – – – – –
– – – – – – 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
– – – – – – 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
– 79 – – 12 135 10 9.2 12 14 21 20 22 23 18 17 18 39 32 28 26 24 22 46 41 49 46 41 40 38 38 38 45 51 49 50 56 53 49 47
– 6.9 – – 12 11 9.9 8.7 11 12 15 14 17 18 13 13 15 24 23 23 23 24 22 22 17 23 20 16 16 15 14 15 23 30 29 30 36 33 30 29
– – – – – – – – – 0.2 1.5 1.8 1.9 1.9 2.0 2.1 2.1 2.2 2.2 1.7 1.5 1.5 1.2 0.4 1.4 2.6 2.3 2.3 2.3 2.3 2.2 2.2 2.8 3.0 3.0 2.9 2.3 2.1 2.2 2.2
– 3.0 – – 6.4 5.1 5.8 3.7 4.8 3.7 5.4 5.6 3.2 7.1 2.4 2.8 4.1 3.3 3.2 3.0 4.1 4.5 4.8 5.1 5.2 3.2 5.6 3.0 1.9 2.0 1.7 2.5 3.5 4.2 6.4 4.7 8.4 3.2 5.6 4.4
– – – – – – 0.0 0.0 0.0 – 5.7 – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
– -84 34 – 24 -59 179 162 145 125 99 76 109 80 56 41 22 132 253 238 223 208 186 162 143 212 184 164 144 126 211 193 167 137 294 258 218 180 374 374
– -85 – – -110 -124 -140 -158 -177 -199 -229 -255 -284 -316 -343 -362 -383 -405 -421 -440 -458 -477 -502 -527 -548 -563 -593 -617 -638 -659 -683 -708 -741 -783 -823 -862 -908 -958 -1,015 -1,069
2.2 1.8 1.3 1.3 1.3 1.3 2.0 2.3 2.3 2.3 2.3 2.3 2.9 3.2 3.2 3.2 3.2 4.7 6.0 7.5 7.5 7.5 7.5 7.5 7.5 8.0 20 20 20 29 38 41 41 54 66 94 94 95 110 144

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?